Dimethyl fumarate
109MS424
Approved small_molecule completed
Quick answer
Dimethyl fumarate for Multiple Sclerosis is a Approved program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen
- Indication
- Multiple Sclerosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed